Zero2IPO Capital is the venture capital arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO’s vast network in China, Zero2IPO Capital does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms in growth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors.
|Origene Technologies||3/10||Series B||$16M||6|
|ShanghaiMed Healthcare||12/07||Series E||$25M||5|